Moreover, the prognostic genes derived from the predictive signature have the potential to modulate the tumorigenesis and progression of COAD, especially NAT1 and NAT2, which have been implicated in modulating antitumor immunity. The gene discussed is NAT2; the disease is colon adenocarcinoma.